Highest-materiality recent filing
Shareholders approved extension of business combination deadline from January 16, 2026 to January 16, 2027.
Extension approved to January 16, 2027; monthly extension payment of $125,000 to be deposited into trust account.
Ribbon Acquisition Corp. shareholders approve one-year extension to complete business combination
Approved extension of business combination deadline from Jan 16, 2026 to Jan 16, 2027.
Ribbon Acquisition Corp. to combine with DRC Medicine in $350M equity value SPAC merger
DRC Medicine designs AI-powered allergy and infection diagnostic kits and protective face masks.
Ribbon Acquisition Corp completes $50M IPO and $2.2M private placement, deposits $50M in trust
IPO of 5,000,000 units at $10.00/unit raised $50,000,000 gross; includes one Class A share and one right.
Effective on January 14, 2025, in connection with the effectiveness of the Registration Statement, Mr. James Zhao-Hui Zhang, Mr. Kani Chen and Mr. Jon Nathan Miller became directors of the Company.
Effective on January 14, 2025, in connection with the effectiveness of the Registration Statement, Mr. James Zhao-Hui Zhang, Mr. Kani Chen and Mr. Jon Nathan Miller became directors of the Company.
Effective on January 14, 2025, in connection with the effectiveness of the Registration Statement, Mr. James Zhao-Hui Zhang, Mr. Kani Chen and Mr. Jon Nathan Miller became directors of the Company.
Max materiality 0.75 · Median 0.30 · Most common event other_material